Dr. Pavlos Msaouel previews his presentation at the ESMO Virtual Congress 2020, and shares interim results a Phase II clinical trial studying multi-target kinase inhibitor sitravatinib in combination with anti-PD-1 drug nivolumab in advanced bladder cancer.
For more information, visit www.mdanderson.org/ESMO.
Request an appointment at MD Anderson by calling 1-877-632-6789 or online at: [ Ссылка ]
